Literature DB >> 28579551

Antiproliferative activity against leukemia cells of sesquiterpene lactones from the Turkish endemic plant Centaurea drabifolia subsp. detonsa.

Carmen Formisano1, Carmina Sirignano2, Daniela Rigano2, Giuseppina Chianese2, Gokhan Zengin3, Ean-Jeong Seo4, Thomas Efferth5, Orazio Taglialatela-Scafati2.   

Abstract

The apolar organic extract obtained from aerial parts of Centaurea drabifolia Sibth. & Sm. subsp. detonsa (Bornm.) Wagenitz, growing wild in Turkey, was investigated for the first time for its secondary metabolite composition. Seven sesquiterpene lactones belonging to the guaiane class (1-7), including the new compound 4, along with a fatty acid lactone derivative (8), were isolated. The structures of these compounds were established by spectroscopic analysis, including 2D NMR spectroscopic techniques, with the stereostructure of the new guaiane 4 determined with the help of MTPA derivatization. Cytotoxic activities of compounds 1-7 were evaluated against two cancer cell lines, namely acute lymphoblastic leukemia (CCRF-CEM) and its multidrug-resistant subline CEM/ADR5000. Results showed that aguerin B (1) and cynaropicrin (2) showed a potent activity on both cell lines revealing interesting details about the structure-activity relationships in the class of acylated guaiane sesquiterpenes.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antileukemic activity; Centaurea drabifolia; Cynaropicrin; Multidrug-resistant cell lines; Sesquiterpene lactones

Mesh:

Substances:

Year:  2017        PMID: 28579551     DOI: 10.1016/j.fitote.2017.05.016

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  1 in total

Review 1.  A Review on Antidiabetic Activity of Centaurea spp.: A New Approach for Developing Herbal Remedies.

Authors:  Samaneh Fattaheian-Dehkordi; Reza Hojjatifard; Mina Saeedi; Mahnaz Khanavi
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-05       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.